AGM/EGMApr 27, 2026, 04:41 PM
NVCT to hold 2026 Annual Meeting on June 11; Elect Director, Ratify Auditor
AI Summary
Nuvectis Pharma, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026. Stockholders will vote on the re-election of Ron Bentsur as a Class I director for a three-year term and the ratification of Kesselman & Kesselman as the independent registered public accounting firm for the year ending December 31, 2026. The record date for voting was April 13, 2026.
Key Highlights
- Annual Meeting of Stockholders to be held virtually on June 11, 2026, at 10:00 a.m. ET.
- Record date for voting is April 13, 2026, with 27,668,036 shares outstanding.
- Stockholders will vote to elect one Class I director for a three-year term.
- Ron Bentsur is nominated for re-election as a Class I director.
- Stockholders will ratify Kesselman & Kesselman as the independent auditor for 2026.
- Directors, executive officers, and 5% beneficial owners hold approximately 39.89% of common stock.
- Dr. Sanchez had one late Form 3 and one late Form 4 filing in 2025.
- Board determined four directors (Hoberman, Kaplan, Oliviero, Sanchez) are independent.
Price Impact
More from NVCT